Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT vs Conventional Radiation for Painful Bone Metastases
NCT06065449Phase 3Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2024
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in bone metastasis (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Pain Response based on International Pain Consensus Criteria at 3 months and Incidence of Adverse Events at 1 year. Started Jan 2024; status: recruiting.
02
Conditions
bone metastasis
Beyond the preview
Go deeper on NCT06065449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06065449.